References
-
1) Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite.
-
2) Molecular insights into human phosphatidylserine synthase 1 reveal its inhibition promotes LDL uptake.
-
3) Metabolic regulation of homologous recombination repair by MRE11 lactylation.
-
4) Brain region-specific action of ketamine as a rapid antidepressant.
-
5) Corynebacterium parakroppenstedtii secretes a novel glycolipid to promote the development of granulomatous lobular mastitis.
-
6) Anti-lymphangiogenesis for boosting drug accumulation in tumors.
-
7) Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis.
-
8) SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl- concentration.
-
9) An orally administered glucose-responsive polymeric complex for high-efficiency and safe delivery of insulin in mice and pigs.
-
10) Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment.
-
11) An artificial metabzyme for tumour-cell-specific metabolic therapy.
-
12) Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer.
-
13) Anti irradiation nanoparticles shelter immune organ from radio-damage via preventing the IKK/IκB/NF-κB activation.
-
14) Accelerated intestinal wound healing via dual electrostimulation from a soft and biodegradable electronic bandage.
-
15) A pan-KRAS degrader for the treatment of KRAS-mutant cancers.